Skip to main content
. 2021 Mar 31;20(5):e13326. doi: 10.1111/acel.13326

TABLE 2.

RNA Fragments Recovered from AD, AMC Aggregates (RNA‐seq analysis)

Chrom. Region Length 5’ gene 5’ dist. 3’ gene 3’ dist. AD reads AMC reads AD/AMC reads Chi2 p< Transcript or encoded protein
1 633888..634164 277 RP5‐857 K21.3 36389 RP5‐857 K21.4 0 515 1360 0.38 0.0001 Transcribed processed pseudogene
1 2281959..2282363 405 SKI 0 MORN1 38889 1396 1967 0.71 0.0001 Ski proto‐oncogene
1 109100211..109100485 275 SCARNA2 0 RP5‐1065 J22.4 3049 131 98 1.34 0.05 scaRNA, small Cajal‐body specific RNA2, guides mod'n of snRNAs
1 244863775..244864066 292 RP11‐11 N7.5 8277 HNRNPU 0 509 653 0.78 0.004 Heterog. Nuclear Ribonucleoprot. U (transripts 1, 3, 4, 8)
2 32916221..32916538 318 LINC00486 0 AL121656.5 10588 17 5 3.40 0.02 Long Intergenic Non‐Protein Coding RNA 486
2 47335292..47335571 280 CALM2 158690 AC073283.4 0 2728 2093 1.30 0.0002 Uncharacterized transcript
2 148961908..148962183 276 KIF5C 0 LYPD6B 75923 3055 1856 1.65 0.0001 Kinesin Family Member 5C (transcript KIF5C_2)
2 181678574..181678849 276 ITGA4 142386 CERKL 0 107 60 1.78 0.001 Ceramide Kinase Like
2 231460607..231460888 282 AC017104.2 7453 NCL 0 41 27 1.52 N. S. Ceroid‐Lipofuscinosis Neuronal Protein 5 (neurodegenerative lysosome storage disease)
2 233275721..233275994 274 ATG16L1 0 SCARNA5 0 400/11 206/5 1.94/2.2 0.0001 Autophagy Related 16‐Like 1 / scaRNA, small Cajal‐body RNA5
2 240713854..240714163 310 RP11‐118 M12.2 12168 KIF1A 0 2806 4988 0.56 0.0001 Kinesin family member 1A
3 160514943..160515216 274 RNU7‐136P 42526 KPNA4 0 536 232 2.31 0.0001 Karyopherin (Importin) Subunit Alpha 4
6 26204696..26204971 276 HIST1H4E 0 HIST1H2BG 11094 164 304 0.54 0.0001 Histone 1 (AD‐agg‐enriched)
6 34071883..34072162 280 MIR1275 71831 GRM4 0 10689 5521 1.94 0.0001 Glutamate Metabotropic Receptor 4
6 52995648..52995925 278 RN7SK 0 ICK 5353 32569 12138 2.68 0.0001 7SK RNA
6 99408034..99408309 276 COQ3 13829 PNISR 0 206 135 1.53 0.001 PNN Interact. Ser & Arg‐Rich Prot. (Pinin, desmosome assoc. prot.)
7 5529123..5529444 322 MIR589 33205 ACTB 0 1210 1719 0.70 0.0001 beta actin (AD‐agg‐enriched)
7 26200464..26200741 278 CTB−119C2.1 25518 HNRNPA2B1 0 168 99 1.70 0.0002 HnRNP A2/B1 (AD‐agg‐enriched)
8 9903986..9904242 257 MIR597 162217 LINC00599 0 1667 1113 1.50 0.0001 Long Intergenic Non‐Protein Coding RNA
8 27604977..27605252 276 GULOP 15903 CLU 0 156 105 1.49 0.005 Clusterin (a.k.a. ApoJ) (AD‐agg‐enriched)
9 35657748..35658022 275 SIT1 6797 RMRP_1 0 472 184 2.57 0.0001 RNA Component of Mitoch. RNA Processing Endoribonuclease
10 101799051..101799385 335 NPM3 15637 MGEA5 / OGA 0 683 432 1.58 0.0001 Hyaluronidase =OGA, removes O‐GlcNAc modifications
11 35663281..35663611 331 TRIM44 0 KRT18P14 196637 1147 592 1.94 0.0001 Tripartite Motif Containing 44
11 62841562..62841839 278 RP11‐727F15.9 7518 WDR74 0 304 149 2.04 0.0001 WD Repeat Domain 74
11 65502716..65503064 349 AP000769.7 4310 MALAT1_1 0 30539 16494 1.85 0.0001 Metastasis Assoc. Lung Adenocarcinoma Transcr. 1 (Non‐Protein)
11 111911504..111911780 277 RPL37AP8 22029 CRYAB 0 228 216 1.06 N. S. Crystalin A beta, a small HSP (AD‐agg‐enriched)
11 123061064..123061339 276 RPL31P47 9662 HSPA8 0 871 1512 0.58 0.0001 Heat Shock Protein Family A (Hsp70) Member 8 (= HSC70)
12 110281619..110281909 291 ATP2A2 0 RN7SL769P 78542 433 225 1.92 0.0001 SERCA2 ATPase Sarcoplasmic/Endopl. Reticulum Ca2+ Transport2
13 45975357..45975649 293 AL445232.1 60203 ZC3H13 0 372 240 1.55 0.0001 Zinc Finger CCCH‐Type Containing 13
14 20343094..20343370 277 SNORD126 16567 RPPH1 0 2313 634 3.65 0.0001 Ribonuclease P RNA Component H1
14 23321579..23321860 282 PABPN1 0 SLC22A17 24445 341 261 1.31 0.01 Poly(A) Binding Protein Nuclear 1
14 49586595..49586871 277 RNA5SP384 33846 RPS29 0 22800 4958 4.60 0.0001 Ribosomal protein, small subunit 29
14 49853648..49853923 276 RNU6‐539P 13820 Metazoa_SRP_138 0 24010 7554 3.18 0.0001 RNA, cytoplasmic Signal Recognition Particle
14 102084750..102085033 284 RN7SL472P 7277 HSP90AA1 0 186 94 1.98 0.0001 HSP 90 family (AD‐agg‐enriched)
17 6452910..6453209 300 FAM64A 1440 PITPNM3 0 671 520 1.29 0.004 PITPNM 3, Phosphatidylinositol Transfer Protein Memb.‐ Assoc.
17 19187969..19188246 278 KYNUP1 18300 SNORD3A 0 342 99 3.45 0.0001 small nucleolar RNA
17 44911190..44911459 270 AC015936.3 6643 GFAP 0 7051 8989 0.78 0.0002 Glial Fibrillary Acidic Protein, GFAP (AD‐agg‐enriched)
18 49814124..49814400 277 ACAA2 163 RP11‐886H22.1 0 295 139 2.12 0.0001 Transcribed processed pseudogene
19 13298568..13298866 299 CTC−250I14.1 139779 CACNA1A 0 10268 5984 1.72 0.0001 Calcium Voltage‐Gated Channel Subunit Alpha1 A
19 36304598..36304871 274 CTD−3162L10.1 0 LINC00665 8195 556 164 3.39 0.0001 Uncharacterized locus
19 44907737..44908015 279 APOE 0 CTB−129P6.7 1359 1028 1003 1.02 N. S. ApoE, Apolipoprotein E (AD‐agg‐enriched)
19 48645763..48646036 274 DBP 8324 CA11 0 407 573 0.71 0.0002 Carbonic Anhydrase 11
19 49107777..49108115 339 SNRNP70 0 LIN7B 6208 2096 1398 1.50 0.0001 Small Nuclear Ribonucleoprotein U1 Subunit 70
20 23637606..23637888 283 CST9 31729 CST3 0 573 742 0.77 0.003 Cystatin C, Cystatin 3
20 41533110..41533383 274 RP4‐620E11.5 150002 CHD6 0 1245 864 1.44 0.0001 Chromodomain Helicase DNA Binding Protein 6, CHDBP6
21 8258828..8259116 289 RNA5‐8S5 1894 FP671120.6 0 1200 132 9.09 0.0001 Uncharacterized transcript
21 8435771..8435981 211 FP236383.5 0 FP236383.1 96 207 12 17.25 0.0001 Uncharacterized transcript
21 26021821..26022101 281 LLPHP2 258487 APP 0 1477 702 2.10 0.0001 Amyloid precursor protein, APP, A4 (AD‐agg‐enriched)
X 140784311..140784609 299 LINC00632 11631 CDR1 0 36675 62951 0.58 0.0001 Cerebellar Degeneration Related Protein 1, CDRP1

All peaks shown were significant at p < 0.01; peak‐coincident genes (at zero distance from peaks) are indicated by bold font. Read ratios (AD/AMC) and p values for AD‐AMC differences were not corrected for 1.6‐fold higher RNA recovery from AD relative to AMC hippocampus, since all normalized RNA‐seq libraries used 1 µg RNA. “AD‐agg enriched” indicates proteins that were also found to be significantly enriched in AD aggregates relative to controls (Ayyadevara, Balasubramaniam, Parcon, et al., 2016).